MediTox

GLP-certified preclinical toxicology CRO for drug, veterinary and medical device developers in Europe

Konárovice, CzechiaFounded 1999meditox.euWebsite technologies

+ Add to sales board

Recent signals

What changed at MediTox in the last 6 months, newest first. Each line links to its public source.

  • 2 Jun 2026 Public contract · Won €29k public contract from Státní fond životního prostředí ČR: Smlouva č. 7251100220 o poskytnutí podpory ze Státního fondu životního prostředí České republiky smlouvy.gov.cz

Get signals like these for the companies you sell to →

About MediTox

MediTox s.r.o. is a GLP-certified contract research organization that conducts preclinical toxicology and safety studies for human drugs, biologicals, veterinary drugs and medical devices. Its website lists compliance with OECD, EMA/ICH, VICH, FDA and ISO 10993 guidelines, and it describes one of the few European facilities using cats as target animals for veterinary testing.

Customers are pharmaceutical, biotech, veterinary and medical device developers; the website lists reference clients across Europe and India, including Argenta, Virbac, Zentiva and Lupin Pharma. The company presents itself as a service provider that proposes study sets to client projects. It also reports participation in several European grant projects on influenza and SARS vaccines, and a device-related project.

MediTox was founded in 1999 and is headquartered in Konárovice, Czech Republic. The website lists a management board, an expert team and business development staff, and recent participation in BIO-Europe 2026 and Nordic Life Science Days 2026.

Product: Contract GLP preclinical toxicology and safety studies for drugs, biologicals, veterinary products and medical devices.

Public contracts

Contracts MediTox signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.

Customers

1 contract with 1 buyer · 720k CZK

ContractsValue
Státní fond životního prostředí ČR1720k CZK

Open public tenders for MediTox →

Latest contracts

  • 2 Jun 2026 for Státní fond životního prostředí ČR · Smlouva č. 7251100220 o poskytnutí podpory ze Státního fondu životního prostředí České republiky · 720k CZK register

Jobs at MediTox

No open positions listed right now.

Leadership

More biotech & pharma companies

  • MendelFOLD

    Protein structure prediction and allosteric analysis software for researchers and drug discovery teams
    Brno, CzechiaBiotech & pharmaFounded 2024
    Young company
  • MicroCen Trans

    Develops and supplies probiotic cultures and ingredients for cosmetics, food producers, and health-product customers
    Brno, CzechiaBiotech & pharmaFounded 2018
    New on Evolc
  • Mihulka

    Custom synthesis and cGMP production of APIs and intermediates for pharmaceutical and biotech companies
    Opava, CzechiaBiotech & pharmaFounded 2016
    New on Evolc
  • MS Pharm

    Medical literature monitoring and local pharmacovigilance services for pharmaceutical companies across Europe and beyond
    Praha, CzechiaBiotech & pharmaFounded 2015
  • MycoTech

    Contract fermentation R&D, metabolite isolation and bio-formulation for pharma, food and agriculture clients in the Czech Republic
    Opava, CzechiaBiotech & pharmaFounded 2018
    New on Evolc
  • Myhrabc

    Pharmaceutical wholesale distributing medicines to public pharmacies in the Czech Republic
    Praha, CzechiaBiotech & pharmaFounded 1991572 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Backend

  • PHPMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.